» Articles » PMID: 26793433

Fully Automated Segmentation of the Cervical Cord from T1-weighted MRI Using PropSeg: Application to Multiple Sclerosis

Abstract

Spinal cord (SC) atrophy, i.e. a reduction in the SC cross-sectional area (CSA) over time, can be measured by means of image segmentation using magnetic resonance imaging (MRI). However, segmentation methods have been limited by factors relating to reproducibility or sensitivity to change. The purpose of this study was to evaluate a fully automated SC segmentation method (PropSeg), and compare this to a semi-automated active surface (AS) method, in healthy controls (HC) and people with multiple sclerosis (MS). MRI data from 120 people were retrospectively analysed; 26 HC, 21 with clinically isolated syndrome, 26 relapsing remitting MS, 26 primary and 21 secondary progressive MS. MRI data from 40 people returning after one year were also analysed. CSA measurements were obtained within the cervical SC. Reproducibility of the measurements was assessed using the intraclass correlation coefficient (ICC). A comparison between mean CSA changes obtained with the two methods over time was performed using multivariate structural equation regression models. Associations between CSA measures and clinical scores were investigated using linear regression models. Compared to the AS method, the reproducibility of CSA measurements obtained with PropSeg was high, both in patients and in HC, with ICC > 0.98 in all cases. There was no significant difference between PropSeg and AS in terms of detecting change over time. Furthermore, PropSeg provided measures that correlated with physical disability, similar to the AS method. PropSeg is a time-efficient and reliable segmentation method, which requires no manual intervention, and may facilitate large multi-centre neuroprotective trials in progressive MS.

Citing Articles

Systemic inflammation associates with and precedes cord atrophy in progressive multiple sclerosis.

Stuart C, Varatharaj A, Zou Y, Darekar A, Domjan J, Wheeler-Kingshott C Brain Commun. 2024; 6(3):fcae143.

PMID: 38712323 PMC: 11073756. DOI: 10.1093/braincomms/fcae143.


Diffusion Kurtosis Imaging of Neonatal Spinal Cord in Clinical Routine.

Tro R, Roascio M, Tortora D, Severino M, Rossi A, Cohen-Adad J Front Radiol. 2023; 2:794981.

PMID: 37492682 PMC: 10365122. DOI: 10.3389/fradi.2022.794981.


Recent Progress in the Identification of Early Transition Biomarkers from Relapsing-Remitting to Progressive Multiple Sclerosis.

Maier S, Barcutean L, Andone S, Manu D, Sarmasan E, Bajko Z Int J Mol Sci. 2023; 24(5).

PMID: 36901807 PMC: 10002756. DOI: 10.3390/ijms24054375.


Deep Learning-Based Auto-Segmentation of Spinal Cord Internal Structure of Diffusion Tensor Imaging in Cervical Spondylotic Myelopathy.

Fei N, Li G, Wang X, Li J, Hu X, Hu Y Diagnostics (Basel). 2023; 13(5).

PMID: 36899962 PMC: 10000612. DOI: 10.3390/diagnostics13050817.


Automated Cervical Spinal Cord Segmentation in Real-World MRI of Multiple Sclerosis Patients by Optimized Hybrid Residual Attention-Aware Convolutional Neural Networks.

Bueno A, Bosch I, Rodriguez A, Jimenez A, Carreres J, Fernandez M J Digit Imaging. 2022; 35(5):1131-1142.

PMID: 35789447 PMC: 9582086. DOI: 10.1007/s10278-022-00637-4.


References
1.
GANTER P, Prince C, Esiri M . Spinal cord axonal loss in multiple sclerosis: a post-mortem study. Neuropathol Appl Neurobiol. 2000; 25(6):459-67. DOI: 10.1046/j.1365-2990.1999.00205.x. View

2.
De Leener B, Cohen-Adad J, Kadoury S . Automatic Segmentation of the Spinal Cord and Spinal Canal Coupled With Vertebral Labeling. IEEE Trans Med Imaging. 2015; 34(8):1705-18. DOI: 10.1109/TMI.2015.2437192. View

3.
Kalkers N, Barkhof F, Bergers E, Van Schijndel R, Polman C . The effect of the neuroprotective agent riluzole on MRI parameters in primary progressive multiple sclerosis: a pilot study. Mult Scler. 2002; 8(6):532-3. DOI: 10.1191/1352458502ms849xx. View

4.
Leary S, Miller D, Stevenson V, Brex P, Chard D, Thompson A . Interferon beta-1a in primary progressive MS: an exploratory, randomized, controlled trial. Neurology. 2003; 60(1):44-51. DOI: 10.1212/wnl.60.1.44. View

5.
Lin X, Tench C, Evangelou N, Jaspan T, Constantinescu C . Measurement of spinal cord atrophy in multiple sclerosis. J Neuroimaging. 2004; 14(3 Suppl):20S-26S. DOI: 10.1177/1051228404266265. View